Quratis Inc. (KOSDAQ:348080)

Market Cap	38.60B
Revenue	n/a
Net Income	n/a
Shares Out	57.96M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	162,778
Average Volume	715,561
Open	666.00
Previous Close	666.00
Day's Range	650.00 - 675.00
52-Week Range	521.00 - 2,250.00
Beta	n/a
RSI	48.62
Earnings Date	n/a

About Quratis

Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents. The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 348080